Thursday, February 22, 2018 10:15 PM ET
Insider purchase at Allergan (AGN) prolongs buy activity of Last 90 Days
One insider — Matthew M Walsh, Officer — today, bought 24,416 shares of Allergan having a market value of approximately $3,921,665, as revealed in a form 4 document filed with the SEC. There have been 4 insiders with buy/sell transactions in the past 90 days prior to this filing. These trades have resulted in the purchase of 17,630 company shares and the sale of 2,700 company shares over this time period. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 39,346 shares and have averaged 8,949 shares per transaction over this time period.
Over the last 90 days, the number of insider buy/sell trades at Allergan is greater than its 119-company peer group average. The Pharmaceuticals peer group saw 66 buy/sell trades during this period for an average of 0.6 transactions per company. However, the number of shares traded per transaction by Allergan insiders is lower than its peers. Within the peer group there were 1,828,831 shares purchased and 4,299,976 shares sold with company insiders selling 37,442 shares on average over this time period.
Insider buying and selling activity that is significant has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in creating and writing this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2018 UpTick Data Technologies. All rights reserved.